We identified APL and other leukemia cases using ICD identifiers ("APL" (n=24), "non APL-AML" (n=972), lymphoid leukemias ("LL", n=2724) and "other" (n=1850). We fitted linear models to investigate the association between BMI and any of the above leukemic classes. In the case-...
Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer. Leukemia & LymphomaYao YY;Tang Y;Zhu Q;.Gemcitabine,oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed ... Merrouche,Mugneret,J-Y,... - 《Annals of...
A case of acute coronary syndrome manifesting as an adverse effect of all-trans retinoic acid in a lady with acute promyelocytic leukemia who had no other risk factors for cardiovascular disease [1A]. From: Side Effects of Drugs Annual, 2016 ...
We compared mortality among patients with and without COVID in 2020 using chi-square analysis.Results:Of 166795 admissions for acute leukemia, 71.8% were acute myeloid leukemia (AML), 25.2% were acute lymphoblastic leukemia (ALL) and 3.1% were acute promyelocytic leukemia (APML). Overall, ...
Human promyelocytic leukemia cells (HL-60) 0.129 To understand whether perillaldehyde induces a regulated form of cell death and to better understand the stage of cell death, we performed the annexin-V assay. One of the earliest events in most regulated cell deaths, such as apoptosis or necropto...
The most clinically significant application of ATRA is to treat a rare subtype of an acute myeloid leukemia (AML), called acute promyelocytic leukemia (APL). At the first description this subtype was considered the most difficult to treat [20], while it is now considered as highly curable ...